BioPlus Co Ltd (099430)

Currency in KRW
6,920
-60(-0.86%)
Closed·
099430 Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 11 days
099430 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,8907,040
52 wk Range
4,3858,420
Key Statistics
Bid/Ask
6,920.00 / 6,930.00
Prev. Close
6,980
Open
7,000
Day's Range
6,890-7,040
52 wk Range
4,385-8,420
Volume
481.79K
Average Volume (3m)
558.39K
1-Year Change
11.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
099430 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

BioPlus Co Ltd Company Profile

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Employees
121

Compare 099430 to Peers and Sector

Metrics to compare
099430
Peers
Sector
Relationship
P/E Ratio
20.8x10.9x−0.5x
PEG Ratio
−1.96−0.280.00
Price/Book
2.7x1.0x2.6x
Price / LTM Sales
5.1x1.4x3.3x
Upside (Analyst Target)
-38.4%43.4%
Fair Value Upside
Unlock34.4%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 344.20%
Dividend Yield
0.72%
Industry Median 0.93%
Annualised payout
50.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
123.00 / --
Revenue / Forecast
23.00B / 18.20B
EPS Revisions
Last 90 days

099430 Income Statement

People Also Watch

30,400
009830
+0.66%
112,000
000100
-0.18%
15,190
098460
+2.84%
135,400
267250
-0.95%
9,470
003380
-0.42%

FAQ

What Stock Exchange Does BioPlus Trade On?

BioPlus is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for BioPlus?

The stock symbol for BioPlus is "099430."

What Is the BioPlus Market Cap?

As of today, BioPlus market cap is 410.92B.

What Is BioPlus's Earnings Per Share (TTM)?

The BioPlus EPS (TTM) is 344.20.

When Is the Next BioPlus Earnings Date?

BioPlus will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 099430 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioPlus Stock Split?

BioPlus has split 1 times.

How Many Employees Does BioPlus Have?

BioPlus has 121 employees.

What is the current trading status of BioPlus (099430)?

As of 08 Aug 2025, BioPlus (099430) is trading at a price of 6,920.00, with a previous close of 6,980.00. The stock has fluctuated within a day range of 6,890.00 to 7,040.00, while its 52-week range spans from 4,385.00 to 8,420.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.